Kim N. Chi, MD | Authors

Managing CRPC: Improving Symptoms, Survival, or Both?

December 16, 2011

In addition to endeavors to develop new therapeutics, we should anticipate and prioritize studies that will address questions regarding the efficacy of combination therapy, timing and sequencing strategies, and the development of predictive markers to individualize and optimize therapy.